Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist licensed for type 2 diabetes and weight management in the UK Dizziness may result from dehydration due to gastrointestinal side effects, hypoglycaemia when combined with other diabetes medications, or reduced caloric intake Seek urgent medical attention if dizziness occurs with chest pain, severe headache, stroke symptoms, loss of consciousness, or severe abdominal pain Management includes maintaining adequate hydration, rising slowly from sitting or lying positions, monitoring blood glucose levels, and ensuring balanced nutrition Report persistent or concerning symptoms to your GP or via the MHRA Yellow Card Scheme for ongoing medication safety monitoring Table of Contents Understanding Mounjaro and Its Common Side Effects Mounjaro (tirzepatide) is a prescription medicine licensed in the UK for the treatment of type 2 diabetes mellitus
Absence of expected improvement by mid-protocol (4-6 weeks) warrants reassessment
Anti-inflammatory foods include fatty fish, leafy greens, berries, and nuts
Could BPC 157 help with acne scars
For instance, changes in the composition of this phospholipid layer have been observed by researchers, along with their detrimental effects on the bones and joints of individuals with OA